What are the major opportunities in the Ophthalmic Drugs market? What are the strategies for the Ophthalmic Drugs market?

For detailed insights on the major opportunities and strategies in the Ophthalmic Drugs market, Read More

How does the Ophthalmic Drugs market relate to the overall economy and other similar markets?

For detailed insights on Ophthalmic Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Ophthalmic Drugs market growth? SWOT analysis of the Ophthalmic Drugs market.

For detailed insights on the key dynamics influencing the Ophthalmic Drugs market growth and SWOT analysis of the Ophthalmic Drugs industry, Read More

Ophthalmic Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Ophthalmic Drugs Market Report 2026

Name: Ophthalmic Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases), By Dosage Form (Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ophthalmic Drugs Market Overview

• Ophthalmic Drugs market size has reached to $42.25 billion in 2025

• Expected to grow to $61.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%

• Growth Driver: Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market

• Market Trend: Preservative-Free Drug To Provide An Effective Treatment Option

• North America was the largest region in 2025.

What Is Covered Under Ophthalmic Drugs Market?

Ophthalmic drugs refer to a class of pharmaceutical drugs or medicines used for treating diseases that affect the eye or vision. This medication is used to treat eye infections

The main types of ophthalmic drugs are prescription drugs and over-the-counter drugs. Prescription ophthalmic drugs refer to types of drugs that can be obtained only using a licensed doctor's or medical practitioner's prescription. The various class includes anti-allergy, anti-inflammatory, anti-glaucoma, and other class for diseases like dry eye, eye allergy, glaucoma, eye infection, retinal disorders, uveitis, and other diseases. The various dosage forms include liquid ophthalmic drug forms, solid ophthalmic drug forms, semisolid ophthalmic drug forms, and multicompartment drug delivery systems. These are distributed through various distribution channels, such as hospital pharmacies, drug stores, and online pharmacies.

Ophthalmic Drugs Market Global Report 2026 Market Report bar graph

What Is The Ophthalmic Drugs Market Size and Share 2026?

The ophthalmic drugs market size has grown strongly in recent years. It will grow from $42.25 billion in 2025 to $45.24 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing aging population, rising incidence of glaucoma and cataract, growth in ophthalmology clinics, improved access to prescription eye medicines, expansion of hospital pharmacy networks.

What Is The Ophthalmic Drugs Market Growth Forecast?

The ophthalmic drugs market size is expected to see strong growth in the next few years. It will grow to $61.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancement in sustained-release ocular drug delivery, increasing awareness of eye health, growth in retinal disorder treatments, rising healthcare expenditure in emerging economies, expanding otc ophthalmic product adoption. Major trends in the forecast period include rising prevalence of chronic eye disorders, growing demand for dry eye therapies, increased adoption of combination ophthalmic drugs, shift toward preservative-free formulations, expansion of online pharmacies for eye medications.

Book your 30 minutes free consultation with our research experts

Global Ophthalmic Drugs Market Segmentation

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Prescription Drugs: Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

2) By Over-The-Counter Drugs: Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

What Is The Driver Of The Ophthalmic Drugs Market?

The increase in the prevalence of ophthalmic disorders is expected to propel the growth of the ophthalmic drug market going forward. Ophthalmic disorders refer to a disorder or disease that affects the eye and other parts of the eye, causing impairment of vision and other eye ailments. Ophthalmic drugs are pharmaceutical drugs or medicines used for treating diseases that affect the eye or vision, as a result, the increase in the prevalence of ophthalmic disorders increases the demand for the ophthalmic drug market. For instance, in August 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, at least 2.2 billion people worldwide were living with near or distance vision impairment in 2023 over 1 billion of which were preventable or untreated with refractive errors and cataracts as the primary causes, limited intervention reach at just 36% and 17%, respectively. The increase in the prevalence of ophthalmic disorders is driving the ophthalmic drug industry.

Key Players In The Global Ophthalmic Drugs Market

Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa

Global Ophthalmic Drugs Market Trends and Insights

Major companies operating in the ophthalmic drugs market are focused on developing preservative-free drugs such as preservative-free latanoprost to provide an effective treatment option. Preservative-free latanoprost refers to a formulation of the medication latanoprost, which is used to treat conditions such as glaucoma. For instance, in September 2023, Thea Pharma, a US-based pharmaceutical company specializing in the commercialization of eye care products, launched Iyuzeh (latanoprost ophthalmic solution) 0.005%, the first preservative-free latanoprost for primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the US. Iyuzeh, approved by the FDA in December 2022, provides an effective treatment option for over 60 million people globally affected by glaucoma.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Ophthalmic Drugs Market?

In November 2025, Harrow Inc., a U.S.-based provider of ophthalmic disease management solutions, acquired Melt Pharmaceuticals for an undisclosed amount. With this acquisition, Harrow aims to expand its ophthalmic drug portfolio and strengthen its position in procedural sedation by integrating Melt’s non-opioid, non-intravenous sublingual sedation therapies into its broader ophthalmic and outpatient care offerings. Melt Pharmaceuticals is a U.S.-based clinical-stage company developing non-opioid, non-IV oral dissolving tablet sedation therapies for medical procedures across ophthalmology and other outpatient settings.

Regional Insights

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ophthalmic Drugs Market?

The ophthalmic drugs market consists of ophthalmic sales of anti-angiogenic drugs, anti-vascular endothelial growth factor drugs, anti-uveitis drugs, and prostaglandin analogs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ophthalmic Drugs Market Report 2026?

The ophthalmic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Ophthalmic Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$45.24 billion
Revenue Forecast In 2035	$61.21 billion
Growth Rate	CAGR of 7.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Class, Disease, Dosage Form, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck &
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Ophthalmic Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Ophthalmic Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Ophthalmic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Ophthalmic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Prevalence Of Chronic Eye Disorders

4.2.2 Growing Demand For Dry Eye Therapies

4.2.3 Increased Adoption Of Combination Ophthalmic Drugs

4.2.4 Shift Toward Preservative-Free Formulations

4.2.5 Expansion Of Online Pharmacies For Eye Medications

5. Ophthalmic Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Ambulatory Surgical Centers

5.4 Specialty Eye Care Centers

5.5 Retail Pharmacies

6. Ophthalmic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ophthalmic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Ophthalmic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Ophthalmic Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Ophthalmic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Ophthalmic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ophthalmic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ophthalmic Drugs Market Segmentation

9.1. Global Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Drugs, Over-The-Counter Drugs

9.2. Global Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

9.3. Global Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

9.4. Global Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

9.5. Global Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Drug Stores, Online Pharmacies

9.6. Global Ophthalmic Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiglaucoma Agents, Anti-inflammatory Drugs, Antibiotics, Antivirals, Corticosteroids, Other Prescription Drugs

9.7. Global Ophthalmic Drugs Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Artificial Tears, Allergy Relief Medications, Redness Relievers, Ocular Vitamins And Supplements, Other OTC Drugs

10. Ophthalmic Drugs Market Regional And Country Analysis

10.1. Global Ophthalmic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Ophthalmic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ophthalmic Drugs Market

11.1. Asia-Pacific Ophthalmic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ophthalmic Drugs Market

12.1. China Ophthalmic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ophthalmic Drugs Market

13.1. India Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ophthalmic Drugs Market

14.1. Japan Ophthalmic Drugs Market Overview

14.2. Japan Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ophthalmic Drugs Market

15.1. Australia Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ophthalmic Drugs Market

16.1. Indonesia Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ophthalmic Drugs Market

17.1. South Korea Ophthalmic Drugs Market Overview

17.2. South Korea Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ophthalmic Drugs Market

18.1. Taiwan Ophthalmic Drugs Market Overview

18.2. Taiwan Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ophthalmic Drugs Market

19.1. South East Asia Ophthalmic Drugs Market Overview

19.2. South East Asia Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ophthalmic Drugs Market

20.1. Western Europe Ophthalmic Drugs Market Overview

20.2. Western Europe Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ophthalmic Drugs Market

21.1. UK Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ophthalmic Drugs Market

22.1. Germany Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ophthalmic Drugs Market

23.1. France Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ophthalmic Drugs Market

24.1. Italy Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ophthalmic Drugs Market

25.1. Spain Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ophthalmic Drugs Market

26.1. Eastern Europe Ophthalmic Drugs Market Overview

26.2. Eastern Europe Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ophthalmic Drugs Market

27.1. Russia Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ophthalmic Drugs Market

28.1. North America Ophthalmic Drugs Market Overview

28.2. North America Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ophthalmic Drugs Market

29.1. USA Ophthalmic Drugs Market Overview

29.2. USA Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ophthalmic Drugs Market

30.1. Canada Ophthalmic Drugs Market Overview

30.2. Canada Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ophthalmic Drugs Market

31.1. South America Ophthalmic Drugs Market Overview

31.2. South America Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ophthalmic Drugs Market

32.1. Brazil Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ophthalmic Drugs Market

33.1. Middle East Ophthalmic Drugs Market Overview

33.2. Middle East Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ophthalmic Drugs Market

34.1. Africa Ophthalmic Drugs Market Overview

34.2. Africa Ophthalmic Drugs Market, Segmentation By Type, Segmentation By Class, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ophthalmic Drugs Market Regulatory and Investment Landscape

36. Ophthalmic Drugs Market Competitive Landscape And Company Profiles

36.1. Ophthalmic Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Ophthalmic Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Ophthalmic Drugs Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Ophthalmic Drugs Market Other Major And Innovative Companies

Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc.

38. Global Ophthalmic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ophthalmic Drugs Market

40. Ophthalmic Drugs Market High Potential Countries, Segments and Strategies

40.1 Ophthalmic Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Ophthalmic Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Ophthalmic Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Ophthalmic Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Ophthalmic Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Ophthalmic Drugs Market, Supply Chain Analysis

Table 4: Global Ophthalmic Drugs Market, Major Raw Material Providers

Table 5: Global Ophthalmic Drugs Market, Major Resource Providers

Table 6: Global Ophthalmic Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Ophthalmic Drugs Market, Major Distributors And Channel Partners

Table 8: Global Ophthalmic Drugs Market, Key Technologies & Future Trends

Table 9: Global Ophthalmic Drugs Market, Major Trends

Table 10: Global Ophthalmic Drugs Market, Major End Users

Table 11: Global Ophthalmic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Ophthalmic Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Ophthalmic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Ophthalmic Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Ophthalmic Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Ophthalmic Drugs Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Ophthalmic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Ophthalmic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Ophthalmic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Ophthalmic Drugs Market - Company Scoring Matrix

Table 98: AbbVie Inc. Financial Performance

Table 99: Alcon Inc. Financial Performance

Table 100: Bausch & Lomb Incorporated Financial Performance

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: Novartis AG Financial Performance

Table 103: Global Ophthalmic Drugs Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Ophthalmic Drugs Market, Competitive Dashboard

Table 105: Global Ophthalmic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Class, 2025 – 2030

Table 108: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

List Of Figures

Figure 1: Global Ophthalmic Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Ophthalmic Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Ophthalmic Drugs Market, Supply Chain Analysis

Figure 4: Global Ophthalmic Drugs Market, Major Raw Material Providers

Figure 5: Global Ophthalmic Drugs Market, Major Resource Providers

Figure 6: Global Ophthalmic Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Ophthalmic Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Ophthalmic Drugs Market, Key Technologies & Future Trends

Figure 9: Global Ophthalmic Drugs Market, Major Trends

Figure 10: Global Ophthalmic Drugs Market, Major End Users

Figure 11: Global Ophthalmic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Ophthalmic Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Ophthalmic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Ophthalmic Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Ophthalmic Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Ophthalmic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Ophthalmic Drugs Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Ophthalmic Drugs Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Ophthalmic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Ophthalmic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Ophthalmic Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Ophthalmic Drugs Market, Segmentation By Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Ophthalmic Drugs Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Ophthalmic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Ophthalmic Drugs Market - Company Scoring Matrix

Figure 98: AbbVie Inc. Financial Performance

Figure 99: Alcon Inc. Financial Performance

Figure 100: Bausch & Lomb Incorporated Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: Novartis AG Financial Performance

Figure 103: Global Ophthalmic Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Ophthalmic Drugs Market, Competitive Dashboard

Figure 105: Global Ophthalmic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Class, 2025 – 2030

Figure 108: Global, Ophthalmic Drugs Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Ophthalmology Drugs Market 2023 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies or Drug Stores, Other Distribution Channe...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia ), By Route of Administration (Oral, Injecta...

Ophthalmic Devices Market Report 2026 - Global Outlook – By Device (Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmi...

Ocular Drug Delivery Market Report 2026 - Global Outlook – By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies), By Formulati...

Ocular Inflammation Treatment Market Report 2026 - Global Outlook – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode Of Operation (Injectables, O...

Ophthalmic Packaging Market Report 2026 - Global Outlook – By Dose (Multi-Dose, Single Dose), By Material (Glass, Plastic, Other Material), By End-Use (Over the Counter (OTC), Prescription) – Market Size, Trends, Strateg...

Ophthalmic Drugs Market Report 2026 - Global Outlook – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Gla...

Frequently Asked Questions

How big is the Ophthalmic Drugs Market?

The Ophthalmic Drugs market was valued at $42.25 billion in 2025, increased to $45.24 billion in 2026, and is projected to reach $61.21 billion by 2030. request a sample here

What is the Ophthalmic Drugs market growth?

The global Ophthalmic Drugs market is expected to grow at a CAGR of 7.9% from 2026 to 2035 to reach $61.21 billion by 2035. request a sample here

Who are the key players in Ophthalmic Drugs market?

Some Key Players in the Ophthalmic Drugs market Include, AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Nicox S.A., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Viatris Inc., Akorn Incorporated, GlaxoSmithKline plc, Bayer AG, Senju Pharmaceutical Co. Ltd., Aerie Pharmaceuticals Inc., Kala Pharmaceuticals Inc., Aurobindo Pharma Ltd., Eyevance Pharmaceuticals, Acucela Inc., Dompe Farmaceutici S.p.A., Laboratoires Théa . request a sample here

What is the anticipated growth trend for the Ophthalmic Drugs market?

Major trend in this market includes: Preservative-Free Drug To Provide An Effective Treatment Option. For further insights on this market. request a sample here

Which region has the most growth potential in the Ophthalmic Drugs market?

North America was the largest region in the ophthalmic drugs market in 2025. The regions covered in the ophthalmic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Ophthalmic Drugs Market Report 2026 market?

Major companies operating in the Ophthalmic Drugs Market Report 2026 market are Major companies operating in the ophthalmic drugs market are AbbVie Inc., Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Regen request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us